CD70 and non-small cell lung carcinoma: Furthermore, during epithelial‐to‐mesenchymal transition (EMT) of non–small cell lung cancer (NSCLC) cells, particularly within drug‐tolerant persister ones associated with EGFR‐TKI resistance, CD70 is upregulated.